Ligand Pharmaceuticals Income Statement

Financials in millions MYR. Fiscal year is June - May.

Millions MYR. Fiscal year is Jun - May.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov '24 Nov 30, 2024	May '24 May 31, 2024	May '23 May 31, 2023	May '22 May 31, 2022	May '21 May 31, 2021	May '20 May 31, 2020
Revenue	29.79	28.92	27.48	16.55	25.35	9.48
Revenue Growth (YoY)	7.33%	5.22%	66.05%	-34.70%	167.42%	-
Cost of Revenue	14.2	13.62	13.42	9.92	17.14	6.77
Gross Profit	15.59	15.3	14.06	6.63	8.2	2.71
Selling, General & Admin	13.01	12.46	11.62	5.08	5.56	1.86
Other Operating Expenses	2.56	2.4	1.47	0.72	0.44	0.22
Operating Expenses	15.57	14.86	13.1	5.8	6.01	2.08
Operating Income	0.02	0.44	0.96	0.83	2.2	0.63
Interest Expense	-0.95	-0.77	-0.37	-0.21	-0.12	-0.06
Interest & Investment Income	0.02	0.02	0.01	-	-	-
Other Non Operating Income (Expenses)	-0.07	-0.07	-0.1	-	-	-
EBT Excluding Unusual Items	-0.99	-0.39	0.5	0.62	2.08	0.56
Gain (Loss) on Sale of Assets	0.01	0.01	-	-	-	-
Other Unusual Items	0.05	0.05	0.03	-	-	-
Pretax Income	-0.92	-0.32	0.53	0.62	2.08	0.56
Income Tax Expense	0.02	0.13	0.43	0.35	0.54	0.11
Net Income	-0.94	-0.45	0.1	0.27	1.54	0.46
Net Income to Common	-0.94	-0.45	0.1	0.27	1.54	0.46
Net Income Growth	-	-	-63.94%	-82.50%	237.25%	-
Shares Outstanding (Basic)	211	211	211	109	0	0
Shares Outstanding (Diluted)	211	211	211	109	0	0
Shares Change (YoY)	-	-	94.02%	75050.87%	325.00%	-
EPS (Basic)	-0.00	-0.00	0.00	0.00	10.63	13.39
EPS (Diluted)	-0.00	-0.00	0.00	0.00	10.63	13.39
EPS Growth	-	-	-81.45%	-99.98%	-20.65%	-
Free Cash Flow	2.3	-4.54	-2.85	-3.43	1.13	-0.06
Free Cash Flow Per Share	0.01	-0.02	-0.01	-0.03	7.83	-1.75
Dividend Per Share	-	-	0.002	-	2.500	-
Gross Margin	52.32%	52.90%	51.15%	40.06%	32.37%	28.62%
Operating Margin	0.07%	1.52%	3.51%	5.03%	8.67%	6.62%
Profit Margin	-3.15%	-1.55%	0.35%	1.63%	6.07%	4.81%
Free Cash Flow Margin	7.70%	-15.70%	-10.37%	-20.75%	4.47%	-0.63%
EBITDA	0.7	1.12	1.27	0.95	2.56	0.77
EBITDA Margin	2.34%	3.88%	4.63%	5.74%	10.10%	8.09%
D&A For EBITDA	0.68	0.68	0.31	0.12	0.36	0.14
EBIT	0.02	0.44	0.96	0.83	2.2	0.63
EBIT Margin	0.07%	1.52%	3.51%	5.03%	8.67%	6.62%
Effective Tax Rate	-	-	81.58%	56.59%	26.05%	19.04%

Updated Jan 24, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.